The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…
On-Demand Educational Webinars
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…
On-Demand Educational Webinars
Learn how to drive organizational and cultural improvements by utilizing cost, quality, and outcome data in the decision making process. This webinar…
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…
Webcast
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or